tradingkey.logo
tradingkey.logo
Search

Haleon PLC

HLN
Add to Watchlist
9.860USD
0.0000.00%
Close 07/13, 16:00ETQuotes delayed by 15 min
44.63BMarket Cap
35.79P/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+1.44%

1 Month

+8.00%

6 Months

+0.41%

Year to Date

-2.47%

1 Year

-1.00%

Key Figures
9.815Open
9.905High
31.14KVolume
35.79P/E TTM
16.85P/E Dynamic
0.054Dividend TTM
0.00%Turnover Ratio
9.860Prev. Close
9.805Low
258.35KTurnover
30.95P/E Static
2.19P/B
0.54%Div Yield TTM
5.02%ROA
11.42052wk High
-0.02Volume Ratio
1.44BNet Profit
4.53BShares
0.2755EPS TTM
0.13Beta
10.23%ROE
8.71052wk Low
1.01%Amplitude
64.19%Gross Margin
44.63BMarket Cap
11.41Reward/Risk
0.81%Risk Rate

TradingKey Stock Score of Haleon PLC

Currency: USD Updated: 2026-07-13

Key Insights

Haleon PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 65 out of 156 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.63.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Haleon PLC's Score

Industry at a Glance

Industry Ranking
65 / 156
Overall Ranking
142 / 4569
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Haleon PLC Highlights

StrengthsRisks
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 67.00% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 14.95B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 41.40%.
Undervalued
The company’s latest PE is 35.79, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 575.83M shares, increasing 2.05% quarter-over-quarter.
Held by First Eagle Investment
Star Investor First Eagle Investment holds 105.83M shares of this stock.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
10.630
Target Price
+8.91%
Upside Space

Haleon PLC News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 5 analysts
Buy
Current Rating
10.630
Target Price
+8.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Haleon PLC
HLN
5
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36

Indicators

Indicators
Sell(1)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.126
Buy
RSI(14)
65.538
Neutral
STOCH(KDJ)(9,3,3)
79.317
Neutral
ATR(14)
0.175
Low Volatility
CCI(14)
88.379
Neutral
Williams %R
8.756
Overbought
TRIX(12,20)
0.318
Sell
StochRSI(14)
70.680
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
9.784
Buy
MA10
9.652
Buy
MA20
9.355
Buy
MA50
9.206
Buy
MA100
9.660
Buy
MA200
9.707
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Haleon PLC Info

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Ticker SymbolHLN
CompanyHaleon PLC
CEOMcnamara (Brian)
Websitehttps://www.haleon.com/

Shareholders

Shareholders
Shareholders
Proportion
Dodge & Cox
3.42%
Fidelity Management & Research Company LLC
2.08%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.37%
Norges Bank Investment Management (NBIM)
0.36%
Other
93.05%

FAQs

What is the current price of Haleon PLC (HLN)?

The current price of Haleon PLC (HLN) is 9.87.

What is the symbol of Haleon PLC?

The ticker symbol of Haleon PLC is HLN.

What is the 52-week high of Haleon PLC?

The 52-week high of Haleon PLC is 11.42.

What is the 52-week low of Haleon PLC?

The 52-week low of Haleon PLC is 8.71.

What is the market capitalization of Haleon PLC?

The market capitalization of Haleon PLC is 42.91B.

Is Haleon PLC (HLN) currently rated as Buy, Hold, or Sell?

According to analysts, Haleon PLC (HLN) has an overall rating of Buy, with a price target of 10.63.

What is the Earnings Per Share (EPS TTM) of Haleon PLC (HLN)?

The Earnings Per Share (EPS TTM) of Haleon PLC (HLN) is 0.50.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.